biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > huge cash premium buyout

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Nov 08, 2021 6:25pm

103 Views

Post# 34102406

RE:RE:RE:RE:huge cash premium buyout

Lol , if the market thought even close to what some of these people who come across as the high & mighty & always right we would see it. We don't so take your bs & chase it down with the dilution that's coming.

Fuzzy, people who engage in ad hominem attacks are those who are unable to discuss the issues, have poor impulse control, and have little control over their emotions. Do you want to be that guy? Aren't you better than that?

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia